Skip to content

Clinical efficacy of millimeter needle insertion in the treatment of perianal eczema

Clinical efficacy of millimeter needle insertion in the treatment of perianal eczema

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084574
Enrollment
Unknown
Registered
2024-05-20
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perianal Eczema

Interventions

Treatment group:Small fire needle row needle shallow stab
control group:External application of triamcinolone acetonide and econazole cream

Sponsors

South District of Guang'anmen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) It meets the clinical diagnostic criteria of Western medicine for acute or subacute perianal eczema. (2) It meets the diagnostic criteria of perianal eczema of traditional Chinese medicine. (3) 18 to 70 years old, regardless of gender. (4) General vital signs were good. (5) Voluntarily sign the informed consent form, and be able to comply with the medication regulations according to the requirements of clinical research. (6) He did not participate in other clinical studies in the past 3 months.

Exclusion criteria

Exclusion criteria: (1) Those who have used other drugs (such as steroids, antihistamines, immunomodulators, etc.) to treat perianal eczema within 2 weeks before the first visit. (2) Patients with anorectal diseases complicated with surgical indications at the test site who have not been treated by surgery, and patients with skin injury caused by surgery or trauma whose wounds are not healed. (3) Patients with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, immune deficiency diseases, tumors and mental diseases, as well as those with no self-knowledge ability and obvious abnormal liver and kidney functions. (4) Endocrine pruritus (fasting blood glucose > 7mmol / L). (5) Pregnant and lactating women, allergic constitution or known allergic to test drugs. (6) Patients with atopic dermatitis, generalized eczema and any other skin diseases that interfere with the test results.

Design outcomes

Primary

MeasureTime frame
Itch score;

Secondary

MeasureTime frame
Skin lesion diameter;Skin lesion morphology;Exudation situation;

Countries

China

Contacts

Public Contactdubinglin

South District of Guang'anmen Hospital

dubinglin1113@163.com+86 131 4132 9782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026